Publication:
Erectile dysfunction as a predictor of advanced vascular age

dc.contributor.authorDjordjevic, D. (24398182900)
dc.contributor.authorVukovic, I. (23500559400)
dc.contributor.authorMilenkovic Petronic, D. (24923372100)
dc.contributor.authorRadovanovic, G. (14630939900)
dc.contributor.authorSeferovic, J. (23486982900)
dc.contributor.authorMicic, S. (7006493137)
dc.contributor.authorKisic Tepavcevic, D. (57218390033)
dc.date.accessioned2025-07-02T12:28:34Z
dc.date.available2025-07-02T12:28:34Z
dc.date.issued2015
dc.description.abstractVascular age (VA) represents chronological age (CA) adjusted for individual's atherosclerotic burden. The presence of erectile dysfunction (ED) has been considered as a clinical sentinel of premature atherosclerosis. The objective of this study was to explore the predictive value of ED in assessing the discrepancy between VA and CA. In the period from 1 January 2014 to 1 January 2015, all consecutive men referring to the outpatient departments of the Clinics of Urology and Cardiology in Belgrade (Serbia) were considered for enrolment in this cross-sectional study. General exclusion criteria were: age below 18, heart failure, history of myocardial infarction, impaired renal and liver function, acute infection, history of endocrine disease other than type 2 diabetes, pelvic surgery or trauma, and acute coronary syndrome within the last 6 months. According to the presence of ED, hypertension, type 2 diabetes and history of coronary artery disease participants were assigned into five study groups. Hierarchical multiple regression analysis was conducted to identify the predictive value of ED in detection of advanced VA. The mean age of males enrolled in the study was 52.9 ± 7.7 years. The predominance of VA over CA was statistically significantly higher in the group of participants with coexistence of ED and hypertension compared to the group of patients with ED and type 2 diabetes (p = 0.027) and the group of patients with ED (p = 0.014) and control group (p < 0.01). Regression analysis highlighted that ED represented a highly important marker (p < 0.01) of advanced VA, which independently accounted for 6.1% of the variance in the discrepancy between VA and CA. Our study suggests that assessment of ED could be a part of a more comprehensive prediction of patients' advanced VA. Screening among such a highly selected population may help identify those that would most benefit from drug treatments and life style changes. Andrology © 2015 American Society of Andrology and European Academy of Andrology.
dc.identifier.urihttps://doi.org/10.1111/andr.12105
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84957431498&doi=10.1111%2fandr.12105&partnerID=40&md5=5ae6b9560a99f1e441e3dce959ab789b
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/13522
dc.subjectAgeing
dc.subjectEpidemiology
dc.subjectErectile dysfunction
dc.titleErectile dysfunction as a predictor of advanced vascular age
dspace.entity.typePublication

Files